Our novel ensilication technology exploits the growth of protective silica nanoshells on the surface of vaccine components, to prevent degredation which can lead to vaccine spoilage. Once applied, our vaccines can be stored and transported without the need for cold chain infrastructure, preventing wastage, improving shelf-life and increasing vaccine accessibility globally. Ensilication can be applied to protect a wide variety of biomolecules against environmental degradation, eliminating the need for cold chain requirements and propelling the development of more oral and mucosal delivery of vaccines and therapeutics for both animals and humans. We are actively looking for partners to work with us in developing new technologies free from the reliance on the cold chain. Please don't hesitate to contact us if you're interested in finding out more about us and the problem of cold chain dependent vaccines.
Location: United Kingdom
Employees: 1-10
Total raised: $7.18M
Founded date: 2022
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.08.2025 | Seed | $6.08M | Calculus C... |
| 16.01.2023 | Pre-Seed | $1.1M | - |
Mentions in press and media 8
| Date | Title | Description |
| 08.09.2025 | Startup Of The Week: EnsiliTech | Based on over 10 year’s research in silica, EnsiliTech is a Bristol-based deeptech startup. The company’s patent-protected platform is helping to make storage of medicines and vaccines easier, opening global access to treatment. The technol... |
| 29.08.2025 | EnsiliTech Secures €5.2M to Revolutionize Global Medicine Transport | EnsiliTech, a Bristol-based biotech pioneer, just closed a significant €5.2 million seed funding round. This capital injection accelerates its patented Ensilication technology. This innovation eliminates the outdated, expensive cold chain. ... |
| 28.08.2025 | Calculus invests in EnsiliTech as part of £4.5M raise | - |
| 28.08.2025 | EnsiliTech Raises £4.5M in Seed Funding | EnsiliTech, a Bristol, UK-based biotechnology startup, raised £4.5M in Seed funding. The round was led by Eos Advisory and Calculus Capital with participation from Empirical Ventures, Fink Family Office, QantX, Angel Investors Bristol (AIB)... |
| 28.08.2025 | British BioTech startup EnsiliTech raises €5.2 million to cut cold-chain costs in biopharma transport | EnsiliTech, a Bristol-based BioTech startup, has secured €5.2 million in Seed funding to revolutionise the way life-saving medicines are stored and transported globally. The round was led by Eos Advisory and joined by Calculus Capital, Empi... |
| 28.08.2025 | EnsiliTech raises £4.5M to advance medicine formulation | Bristol-based biotechnology startup EnsiliTech has raised its second oversubscribed funding round, securing £4.5 million in seed funding to improve the way life-saving medicines are stored and transported globally. Today’s biopharmaceutical... |
| - | EnsiliTech | “EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals.” |
| - | EnsiliTech | “EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals” |